TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Piramal Pharma Limited ( (IN:PPLPHARMA) ) has shared an update.
Piramal Pharma Limited has commenced commercial production of Sevoflurane at its facility in Digwal, Telangana, India. This expansion enhances the company’s manufacturing capabilities, allowing it to address opportunities in inhalation anesthesia markets beyond the USA, potentially strengthening its industry position and offering broader market access.
More about Piramal Pharma Limited
Piramal Pharma Limited operates in the pharmaceutical industry, focusing on the production of various pharmaceutical products. The company is involved in the manufacture and distribution of inhalation anesthesia products, with a market focus that includes both the USA and Rest of the World (ROW) markets.
YTD Price Performance: -13.04%
Average Trading Volume: 391,520
Current Market Cap: 297.6B INR
See more insights into PPLPHARMA stock on TipRanks’ Stock Analysis page.